What are the limitations of using creatinine as a biomarker in patients with liver disease, irrespective of their alcohol consumption status?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18776704
Cited by: 0

Abstract

Creatinine is a limited biomarker for kidney function in patients with liver disease due to its tendency to overestimate GFR, variability in assay results, and insensitivity to acute renal changes.

Fields of Study & Subjects

Chronic Kidney Disease and Diabetes Liver Disease and Transplantation Acute Kidney Injury Research

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
25 February 2026
Language
EN